Skip to main content
IXHL
NASDAQ Life Sciences

Incannex Healthcare Funds Sleep Apnea Research via AASM Foundation Partnership

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.85
Mkt Cap
$33.205M
52W Low
$2.4
52W High
$49.8
52W Position info
19% above low
Off High info
94% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

IXHL sits 19% above its 52-week low of $2.4.

Summary

Incannex Healthcare Inc. has announced a partnership with the American Academy of Sleep Medicine (AASM) Foundation, joining its Corporate Recognition Program and sponsoring a Focused Projects Grant for junior investigators in sleep apnea research. This collaboration enhances Incannex's credibility and visibility within the sleep medicine community, aligning the company with a respected foundation as it develops IHL-42X for obstructive sleep apnea. The partnership also serves to highlight the ongoing positive progress of IHL-42X, which has received FDA Fast Track designation and is advancing towards patient dosing in the DReAMzz Phase 2 dose-optimization study in the coming months. This strategic engagement, following recent significant cash raises and a strengthened balance sheet, underscores the company's commitment to the field and its lead drug candidate. Investors should watch for updates on the DReAMzz study as a key near-term catalyst.

At the time of this announcement, IXHL was trading at $2.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $33.2M. The 52-week trading range was $2.40 to $49.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

IXHL - Latest Insights

IXHL
Nov 12, 2026, 11:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.01
Real-time Price: $1.79 info
Change: -$0.220 (-11%) info
Market Cap: $21.956M info
IXHL
Nov 12, 2026, 8:29 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.98
Real-time Price: $1.79 info
Change: -$0.190 (-10%) info
Market Cap: $21.956M info
IXHL
Sep 25, 2026, 8:41 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $3.40
Real-time Price: $1.79 info
Change: -$1.61 (-47%) info
Market Cap: $21.956M info
IXHL
Aug 25, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.33
Real-time Price: $1.79 info
Change: -$1.54 (-46%) info
Market Cap: $21.956M info
IXHL
Aug 11, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.33
Real-time Price: $1.79 info
Change: -$1.54 (-46%) info
Market Cap: $21.956M info